Evidence map›Paper›PMID 37494142›Full record

ArticleJournal of diabetes investigation2023

Successful introduction of sensor-augmented pump therapy in a patient with diabetes and needle phobia: A case report.

Keiji Sugai, Junpei Shikuma, Satoshi Hiroike, Hironori Abe, Ryo Suzuki

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of diabetes investigation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Keiji SugaiDepartment of Diabetes, Metabolism and Endocrinology, Tokyo Medical University Hospital, Tokyo, Japan.ORCID https://orcid.org/0000-0003-0354-0849
Junpei ShikumaDepartment of Diabetes, Metabolism and Endocrinology, Tokyo Medical University Hospital, Tokyo, Japan.
Satoshi HiroikeDepartment of Diabetes, Metabolism and Endocrinology, Tokyo Medical University Hospital, Tokyo, Japan.
Hironori AbeDepartment of Diabetes, Metabolism and Endocrinology, Tokyo Medical University Hospital, Tokyo, Japan.
Ryo SuzukiDepartment of Diabetes, Metabolism and Endocrinology, Tokyo Medical University Hospital, Tokyo, Japan.ORCID https://orcid.org/0000-0002-2965-6906
Tokyo Medical University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Needle phobia is a specific phobia classified as an anxiety disorder in the Diagnostic and Statistical Manual of Mental Disorders-5, and can be a serious problem for patients requiring insulin injections. However, there have been few reports to date on the management of adults with diabetes and needle phobia. We here report a case of a woman with pancreatic diabetes who developed needle phobia and could no longer perform self-injections. She started to use a sensor-augmented pump (SAP), and was able to perform a puncture for the insulin pump and the continuous glucose monitoring sensor by herself. The SAP treatment achieved self-management, better glycemic control, and high treatment satisfaction quantified using the Diabetes Treatment Satisfaction Questionnaire in this patient. Our case suggests the therapeutic potential of SAP in adults with needle phobia and diabetes requiring insulin therapy.

Indexed as

Diabetes Mellitus, Type 1Phobic DisordersAdultBlood GlucoseBlood Glucose Self-MonitoringFemaleHumansHypoglycemic AgentsInsulinBlood GlucoseHypoglycemic AgentsInsulinInsulin pumpNeedle phobiaSensor-augmented pump

Identifiers

PMID37494142
PMCPMC10583640
OpenAlexW4385283285

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.